Charvalos E - Search Results

1

New nystatin polymeric complexes and their in vitro antifungal evaluation in a model study with Fusarium oxysporum.

Charvalos E, Tsatsakis A, Tzatzarakis M, Dolapsakis G, Stiakakis J. Charvalos E, et al. Mycopathologia. 2002;153(1):15-9. doi: 10.1023/a:1015252121285. Mycopathologia. 2002. PMID: 11913760

2

Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum.

Tzatzarakis MN, Tsatsakis AM, Charvalos E, Vakalounakis D. Tzatzarakis MN, et al. Among authors: charvalos e. J Environ Sci Health B. 2001 May;36(3):331-40. doi: 10.1081/PFC-100103573. J Environ Sci Health B. 2001. PMID: 11411855

3

Controlled release of water-soluble polymeric complexes of sorbic acid with antifungal activities.

Charvalos E, Tzatzarakis M, Tsatsakis A, Petrikkos G. Charvalos E, et al. Appl Microbiol Biotechnol. 2001 Dec;57(5-6):770-5. doi: 10.1007/s00253-001-0853-z. Appl Microbiol Biotechnol. 2001. PMID: 11778892

4

Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.

Charvalos E, Tzatzarakis MN, Van Bambeke F, Tulkens PM, Tsatsakis AM, Tzanakakis GN, Mingeot-Leclercq MP. Charvalos E, et al. J Antimicrob Chemother. 2006 Feb;57(2):236-44. doi: 10.1093/jac/dki455. Epub 2005 Dec 16. J Antimicrob Chemother. 2006. PMID: 16361329

5

Antimicrobial activity of argon fluoride (ArF) excimer laser on gram-negative bacteria.

Charvalos E, Karoutis A. Charvalos E, et al. Appl Microbiol Biotechnol. 2001 Jul;56(1-2):243-8. doi: 10.1007/s002530100611. Appl Microbiol Biotechnol. 2001. PMID: 11499938

6

Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections.

Petrikkos GL, Christofilopoulou SA, Tentolouris NK, Charvalos EA, Kosmidis CJ, Daikos GL. Petrikkos GL, et al. Among authors: charvalos ea. Eur J Clin Microbiol Infect Dis. 2005 Apr;24(4):272-5. doi: 10.1007/s10096-005-1312-z. Eur J Clin Microbiol Infect Dis. 2005. PMID: 15902534

7

Could procalcitonin be a predictive biological marker in systemic fungal infections?. Study of 14 cases.

Christofilopoulou S, Charvalos E, Petrikkos G. Christofilopoulou S, et al. Among authors: charvalos e. Eur J Intern Med. 2002 Dec;13(8):493-495. doi: 10.1016/s0953-6205(02)00160-7. Eur J Intern Med. 2002. PMID: 12446193

8

Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni.

Charvalos E, Tselentis Y, Hamzehpour MM, Köhler T, Pechere JC. Charvalos E, et al. Antimicrob Agents Chemother. 1995 Sep;39(9):2019-22. doi: 10.1128/AAC.39.9.2019. Antimicrob Agents Chemother. 1995. PMID: 8540709 Free PMC article.

9

Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing.

Charvalos E, Peteinaki E, Spyridaki I, Manetas S, Tselentis Y. Charvalos E, et al. J Clin Lab Anal. 1996;10(3):129-33. doi: 10.1002/(SICI)1098-2825(1996)10:3<129::AID-JCLA3>3.0.CO;2-6. J Clin Lab Anal. 1996. PMID: 8731499

10

Epidemiological study of brucellosis in eight Greek villages using a computerised mapping programme.

Hadjichristodoulou C, Papatheodorou C, Soteriades E, Panagakos G, Kastritis I, Goutziana G, Charvalos E, Tselentis Y. Hadjichristodoulou C, et al. Among authors: charvalos e. Eur J Epidemiol. 1999 Aug;15(7):671-80. doi: 10.1023/a:1007673318947. Eur J Epidemiol. 1999. PMID: 10543359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters